Planning a Specialty Drug Strategy Through 2020
Gregory Judd, CEBS, CLU, ChFC, leads Benefits Information Group, a provider of employee benefit plan market intelligence. Randy Vogenberg, PhD, RPh, principal at the Institute for Integrated Healthcare and partner at Access Market Intelligence, is a national expert on managed care and health innovation research. Currently, he is co-project leader for the National Employer Initiative on Biologics & Specialty Drugs with the Midwest Business Group on Health.
- Member for
- 8 years 7 months